Bristol-Myers Squibb Company (BMY) Consensus Estimates Analysis

Bristol-Myers Squibb Company (BMY) Consensus Estimates Analysis

Bristol-Myers Squibb Company (BMY) Consensus Estimates Analysis

About 616,769 shares traded or 68.32% up from the average.

News headlines about Bristol-Myers Squibb (NYSE:BMY) have trended positive recently, Accern Sentiment reports. It has underperformed by 39.89% the S&P500.

By tracking previous views Nektar Therapeutics (NASDAQ:NKTR) also in plain sight to attract passive investors, shares in most recent trading session are surging -2.79% after traded at $55.05. Amazon.Com Inc now has $566.73 billion valuation. The stock increased 3.96% or $0.92 during the last trading session, reaching $24.16. The shares were sold at an average price of $63.37, for a total transaction of $9,922,601.34. CVB Financial Corp. (NASDAQ:CVBF) has risen 23.35% since December 15, 2016 and is uptrending. It has outperformed by 17.82% the S&P500.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 100% are positive. Bristol-Myers Squibb Company had 69 analyst reports since July 28, 2015 according to SRatingsIntel. Cowen & Co maintained FLY Leasing Limited (NYSE:FLY) on Monday, August 14 with "Buy" rating. The firm has "Sell" rating given on Sunday, July 23 by BMO Capital Markets. The firm has "Conviction Buy" rating by Goldman Sachs given on Wednesday, July 22. Canaccord Genuity has "Buy" rating and $65 target. This defines the most likely future of the stock price of Bristol-Myers Squibb Company. On Wednesday, August 16 the stock rating was maintained by BMO Capital Markets with "Sell". As per Tuesday, September 12, the company rating was downgraded by Hilliard Lyons.

Investors sentiment decreased to 0.95 in 2017 Q2. Its up 0.08, from 0.95 in 2017Q1. It turned negative, as 78 investors sold BMY shares while 520 reduced holdings.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. A thorough research report will typically provide detailed reasoning for a certain target projection. Lpl stated it has 0.1% in Bristol-Myers Squibb Company (NYSE:BMY). Meag Munich Ergo Kapitalanlagegesellschaft Mbh owns 113,429 shares for 0.28% of their portfolio. Cadence Savings Bank Na has 16,810 shares for 0.43% of their portfolio.

Bristol-Myers Squibb Company (BMY) traded up $0.28 during mid-day trading on Friday, reaching $62.41. Following the transaction, the executive vice president now directly owns 584,373 shares of the company's stock, valued at approximately $37,031,717.01. Main Street Lc has invested 0.31% in Bristol-Myers Squibb Company (NYSE:BMY). Berson & Corrado Investment Advisors Llc bought 43,230 shares as the company's stock declined 8.75% while stock markets rallied. Opus Management has invested 0.42% in Bristol-Myers Squibb Company (NYSE:BMY). Overbrook Mngmt Corporation reported 16,300 shares or 0.2% of all its holdings. Finally, Leerink Swann increased their target price on shares of Bristol-Myers Squibb from $61.00 to $72.00 and gave the stock an "outperform" rating in a research note on Monday, October 23rd. (NASDAQ:AAPL). Barrow Hanley Mewhinney Strauss Ltd Company owns 0.14% invested in Apple Inc.

Since September 6, 2017, it had 0 insider purchases, and 2 insider sales for $895,572 activity. $335,172 worth of Bristol-Myers Squibb Company (NYSE:BMY) was sold by Lynch Thomas J. Jr.

Polaris Wealth Advisers Llc decreased Alphabet Inc stake by 630 shares to 274 valued at $255,000 in 2017Q2. Oppenheimer & Co. Inc. boosted its stake in shares of Bristol-Myers Squibb by 2.5% during the 2nd quarter. (NYSE:C). Ci Glob Invests invested 0.59% in Citigroup Inc. The company has a current ratio of 1.59, a quick ratio of 1.46 and a debt-to-equity ratio of 0.47. Its down 0.03, from 0.98 in 2017Q1. It turned negative, as 48 investors sold XOM shares while 822 reduced holdings. Jarislowsky Fraser Ltd, a Quebec - Canada-based fund reported 10.26 million shares. Aqr Cap Mngmt Lc has 0.66% invested in, Inc. (NASDAQ:AAPL) for 10,000 shares. Freestone Cap Ltd has 0.06% invested in, Inc.

Investors are always on the look for the next great stock to own. Wms Limited Liability Company holds 155,100 shares. Notis stated it has 0.55% of its portfolio in Bristol-Myers Squibb Company (NYSE:BMY). (NASDAQ:AMZN). Thompson Davis & Incorporated owns 705 shares for 1.1% of their portfolio. Shufro Rose And Llc holds 582,592 shares or 3.47% of its portfolio. Toronto Dominion Bank boosted its stake in shares of Bristol-Myers Squibb by 54.0% during the 1st quarter. Davidson And Garrard, a Virginia-based fund reported 48,483 shares.

Analysts await, Inc. Focused Wealth Mgmt reported 1.47% stake.

The shares price has swapped 6.21% toward a higher level throughout a year ago and directed 1.44% toward a strong spot during past one month. MSFT's profit will be $6.63B for 25.25 P/E if the $0.86 EPS becomes a reality. The biopharmaceutical company reported $0.75 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.77 by ($0.02). Palouse Cap Management Inc accumulated 64,584 shares. (NASDAQ:AAPL) was sold by SCHILLER PHILIP W on Tuesday, October 3.

Among 9 analysts covering Heico Corporation (NYSE:HEI), 5 have Buy rating, 0 Sell and 4 Hold. Therefore 94% are positive.

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Zacks downgraded the stock to "Hold" rating in Thursday, August 27 report. Barclays Capital maintained the stock with "Equal Weight" rating in Friday, April 29 report. Jefferies maintained KKR & Co. Credit Suisse maintained Apple Inc. Macquarie Research has "Underperform" rating and $60 target. As per Tuesday, May 3, the company rating was maintained by Nomura. As per Thursday, October 26, the company rating was maintained by Piper Jaffray. RBC Capital Markets maintained the shares of FLY in report on Monday, April 24 with "Buy" rating. Rock Springs Capital Mgmt LP has invested 0.14% in Bristol-Myers Squibb Company (NYSE:BMY).

Several research firms have recently weighed in on BMY.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Notícias recomendadas

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.